Orion Oyj (LTS:0M2O) Debt-to-Asset : 0.18 (As of Jun. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Orion Oyj Debt-to-Asset?

Orion Oyj's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €30 Mil. Orion Oyj's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was €234 Mil. Orion Oyj's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2024 was €1,457 Mil. Orion Oyj's debt to asset for the quarter that ended in Jun. 2024 was 0.18.

Orion Oyj Debt-to-Asset Historical Data

The historical data trend for Orion Oyj's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Debt-to-Asset Chart

Orion Oyj Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.01

0.10

0.14

Orion Oyj Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Debt-to-Asset	Get a 7-Day Free Trial															0.16	0.15	0.14	0.13	0.18

Competitive Comparison of Orion Oyj's Debt-to-Asset

For the Drug Manufacturers - General subindustry, Orion Oyj's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Oyj's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Oyj's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Orion Oyj's Debt-to-Asset falls into.

Orion Oyj Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Orion Oyj's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(29.1	+	171)	/	1438.6
	=	0.14

Orion Oyj's Debt-to-Asset for the quarter that ended in Jun. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(29.6	+	234.1)	/	1457.3
	=	0.18

Orion Oyj (LTS:0M2O) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Orion Oyj Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Orion Oyj's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Oyj Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (LTS:0M2O) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

ORINY:USA 1ORNBV:Italy ORNBVh:UK 0M2N:UK ORNBV:Finland ORNAV:Finland OFK:Germany

Address

Orionintie 1, Espoo, FIN, FI-02200

Website

https://www.orion.fi

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines